LT2654770T - Tenekteplazės farmacinės kompozicijos - Google Patents

Tenekteplazės farmacinės kompozicijos

Info

Publication number
LT2654770T
LT2654770T LTEP11851346.4T LT11851346T LT2654770T LT 2654770 T LT2654770 T LT 2654770T LT 11851346 T LT11851346 T LT 11851346T LT 2654770 T LT2654770 T LT 2654770T
Authority
LT
Lithuania
Prior art keywords
tenecteplase
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
LTEP11851346.4T
Other languages
English (en)
Inventor
Sanjay Singh
Maheshwari Kumar MISHRA
Pritiranjan BHANDARI
Original Assignee
Gennova Biopharmaceuticals Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46313261&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LT2654770(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gennova Biopharmaceuticals Ltd. filed Critical Gennova Biopharmaceuticals Ltd.
Publication of LT2654770T publication Critical patent/LT2654770T/lt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482Serine endopeptidases (3.4.21)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21068Tissue plasminogen activator (3.4.21.68), i.e. tPA

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
LTEP11851346.4T 2010-12-23 2011-12-16 Tenekteplazės farmacinės kompozicijos LT2654770T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN3516MU2010 2010-12-23
PCT/IN2011/000863 WO2012085933A1 (en) 2010-12-23 2011-12-16 Pharmaceutical compositions of tenecteplase

Publications (1)

Publication Number Publication Date
LT2654770T true LT2654770T (lt) 2018-09-10

Family

ID=46313261

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP11851346.4T LT2654770T (lt) 2010-12-23 2011-12-16 Tenekteplazės farmacinės kompozicijos

Country Status (17)

Country Link
US (2) US20130323227A1 (lt)
EP (1) EP2654770B1 (lt)
JP (1) JP6375112B2 (lt)
CN (1) CN103391785A (lt)
AU (1) AU2011346515B2 (lt)
BR (1) BR112013015914B1 (lt)
CO (1) CO6721059A2 (lt)
DK (1) DK2654770T3 (lt)
EA (1) EA026017B1 (lt)
ES (1) ES2687850T3 (lt)
LT (1) LT2654770T (lt)
MX (1) MX356199B (lt)
MY (1) MY171723A (lt)
NZ (1) NZ611706A (lt)
PL (1) PL2654770T3 (lt)
PT (1) PT2654770T (lt)
WO (1) WO2012085933A1 (lt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7086601B2 (ja) * 2014-10-21 2022-06-20 ジェンノヴァ バイオファーマシューティカルズ リミテッド 組換えtnk-tpa(テネクテプラーゼ)の単離及び商業生産のための新規精製方法
WO2018210860A1 (en) * 2017-05-16 2018-11-22 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of acute ischemic stroke
EP3802780A4 (en) * 2018-06-01 2022-03-23 Gennova Biopharmaceuticals Limited METHOD FOR PRODUCING RECOMBINANT TNK-TPA BY A PACKED BED INFUSION SYSTEM

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10230752A1 (de) * 2002-07-09 2004-01-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkompositionen auf der Basis von Magnesiumsalzen und Fibrinolytika
US20070014779A1 (en) * 2002-11-14 2007-01-18 Genentech, Inc. Plasminogen activator variant formulations
US20070166299A1 (en) * 2005-03-02 2007-07-19 The Regents Of The University Of California Treatment for embolic stroke
WO2006094120A2 (en) * 2005-03-02 2006-09-08 The Regents Of The University Of California Treatment for embolic stroke
SG10201804944XA (en) * 2006-08-29 2018-07-30 Genentech Inc Use of tenecteplase for treating acute ischemic stroke
EP2086571A2 (en) * 2006-11-07 2009-08-12 Genentech, Inc. Tissue plasminogen activator variant uses
EP2014760A1 (en) * 2007-06-13 2009-01-14 CMC Biopharmaceuticals A/S A method for producing a biopolymer (e.g. polypeptide) in a continuous fermentation process

Also Published As

Publication number Publication date
BR112013015914A2 (pt) 2016-10-11
US9943575B2 (en) 2018-04-17
US20160310580A1 (en) 2016-10-27
AU2011346515A1 (en) 2013-07-04
NZ611706A (en) 2015-04-24
EP2654770B1 (en) 2018-07-11
AU2011346515B2 (en) 2017-01-19
CN103391785A (zh) 2013-11-13
EA026017B1 (ru) 2017-02-28
ES2687850T3 (es) 2018-10-29
EA201300746A1 (ru) 2013-11-29
MX2013007381A (es) 2013-08-29
EP2654770A1 (en) 2013-10-30
PL2654770T3 (pl) 2018-12-31
JP2014502608A (ja) 2014-02-03
EP2654770A4 (en) 2014-05-21
JP6375112B2 (ja) 2018-08-15
BR112013015914B1 (pt) 2021-06-08
CO6721059A2 (es) 2013-07-31
WO2012085933A1 (en) 2012-06-28
MY171723A (en) 2019-10-24
MX356199B (es) 2018-05-18
DK2654770T3 (en) 2018-10-29
PT2654770T (pt) 2018-10-19
US20130323227A1 (en) 2013-12-05

Similar Documents

Publication Publication Date Title
ZA201300458B (en) C-met-modulator pharmaceutical compositions
RS56220B1 (sr) Farmaceutski sastav karbetocina
ZA201301766B (en) Pharmaceutical compositions
ZA201300718B (en) Pharmaceutical compositions
ZA201207670B (en) Pharmaceutical compositions
EP2616053A4 (en) PHARMACEUTICAL COMPOSITIONS FROM CURCUMIN
ZA201303223B (en) Pharmaceutical compositions
EP2637655A4 (en) PHARMACEUTICAL COMPOSITION OF TAXOIDES
ZA201302560B (en) Pharmaceutical topical composition of mupirocin
ZA201303177B (en) Pharmaceutical compositions
PT2654770T (pt) Composições farmacêuticas de tenecteplase
PL2471520T3 (pl) Kompozycja farmaceutyczna lewetyracetamu
PL2407159T3 (pl) Kompozycje farmaceutyczne olmesartanu
EP2543373A4 (en) PHARMACEUTICAL COMPOSITION OF LEVOAMLODIPINE COMPOUND
EP2560678A4 (en) PHARMACEUTICAL COMPOSITIONS
GB201407689D0 (en) Pharmaceutical compositions of antihypertensives
ZA201303732B (en) Pharmaceutical compositions
GB201008590D0 (en) Pharmaceutical compositions